The pooled prevalence of stroke/TIA among patients with TA was 10.7% in the literature, with higher rates found among men and European populations.

Many of the randomized controlled trials for large vessel vasculitis with significant or nonsignificant outcomes show fragility, and measures do not vary with the risk for bias, drug type, or subtype.

A study finds the combination of mycophenolate mofetil and methotrexate is more effective and safer than a regimen of cyclophosphamide followed by azathioprine for treating Takayasu arteritis.

High ischemic deficits on CT perfusion scans predict stroke risk in Takayasu arteritis, new study shows, underscoring need for early risk assessment.

Results of a systematic review showed that cognitive impairment and neuropsychiatric manifestations are common among patients with various forms of vasculitis.

RINVOQ is the first and only oral advanced therapy approved for the treatment of giant cell arteritis (GCA) in Canadian adults 1 GCA is the most common vasculitis in Canada, primarily affecting adults ...

(RTTNews) - AbbVie Inc. (ABBV), Wednesday announced Health Canada has issued a Notice of Compliance for RINVOQ for the treatment of adults with giant cell arteritis, both used in combination with a ...

Kazuaki Yamashita, who was sent to fight in the Battle of Okinawa during World War II and lost many friends, is pictured in Kunisaki, Oita Prefecture, on Aug. 5, 2025. A scar from a gunshot wound ...

MONTREAL, Aug. 27, 2025 /CNW/ - AbbVie today announced that Health Canada has issued a Notice of Compliance for RINVOQ ® (upadacitinib) for the treatment of adults with giant cell arteritis (GCA), ...

Jake Rosen is a reporter covering the Department of Justice. He was previously a campaign digital reporter covering President Trump's 2024 campaign and also served as an associate producer for "Face ...

Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell arteritis (GCA), a debilitating autoimmune disease affecting the arteries. In the ...